Covered recipient · General Payments record
RACHEL MAUDE BREAULT
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,006.07
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $185.11 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $43.50 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $32.69 | 1 |
| AngioDynamics, Inc. | $29.76 | 1 |
| Silk Road Medical, Inc. | $17.18 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.67 | 1 |
| Merck Sharp & Dohme Corporation | $15.66 | 1 |
| CORDIS US CORP. | $15.64 | 1 |
| Novo Nordisk AS | $14.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AngioDynamics, Inc. | $29.76 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095102978 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.09 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104409103 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.41 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104238165 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.67 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118014848 | CMS |
| Boston Scientific Corporation | $32.69 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092554944 | CMS |
| CORDIS US CORP. | $15.64 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145403854 | CMS |
| Merck Sharp & Dohme LLC | $15.66 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141790498 | CMS |
| Novo Nordisk Inc | $14.01 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100510601 | CMS |
| Silk Road Medical, Inc. | $17.18 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082261976 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.